HC
TECH icon

Hurley Capital’s Bio-Techne TECH Stock Holding History

Hurley Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-131
Closed -$7.69K – 756
2025
Q4 		$7.69K Sell
131
-10
-7% -$608 ﹤0.01% 360
2025
Q3 		$7.82K Buy
141
+11
+8% +$589 ﹤0.01% 391
2025
Q2 		$6.71K Hold
130
– – ﹤0.01% 345
2025
Q1 		$7.63K Hold
130
– – 0.01% 348
2024
Q4 		$9.96K Buy
+130
New +$9.55K 0.01% 279

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hurley Capital's TECH Position: Q1 2026 in Review

Hurley Capital sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 131 shares — an estimated $7.69K sold.

Hurley Capital first reported a position in TECH in Q4 2024 and held it in 5 quarters. The position peaked at $9.96K in Q4 2024. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Hurley Capital reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Hurley Capital sold 131 Bio-Techne shares in Q1 2026, an estimated $7.69K.
  • Hurley Capital first reported a position in Bio-Techne in Q4 2024 and held it in 5 quarters.
  • Hurley Capital's Bio-Techne position peaked at $9.96K in Q4 2024.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.